223 related articles for article (PubMed ID: 22318725)
1. Ubiquitin- and MDM2 E3 ligase-independent proteasomal turnover of nucleostemin in response to GTP depletion.
Lo D; Dai MS; Sun XX; Zeng SX; Lu H
J Biol Chem; 2012 Mar; 287(13):10013-10020. PubMed ID: 22318725
[TBL] [Abstract][Full Text] [Related]
2. Depletion of guanine nucleotides leads to the Mdm2-dependent proteasomal degradation of nucleostemin.
Huang M; Itahana K; Zhang Y; Mitchell BS
Cancer Res; 2009 Apr; 69(7):3004-12. PubMed ID: 19318567
[TBL] [Abstract][Full Text] [Related]
3. Nucleostemin: Another nucleolar "Twister" of the p53-MDM2 loop.
Lo D; Lu H
Cell Cycle; 2010 Aug; 9(16):3227-32. PubMed ID: 20703089
[TBL] [Abstract][Full Text] [Related]
4. The degradation of p53 and its major E3 ligase Mdm2 is differentially dependent on the proteasomal ubiquitin receptor S5a.
Sparks A; Dayal S; Das J; Robertson P; Menendez S; Saville MK
Oncogene; 2014 Sep; 33(38):4685-96. PubMed ID: 24121268
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2.
Dai MS; Sun XX; Lu H
Mol Cell Biol; 2008 Jul; 28(13):4365-76. PubMed ID: 18426907
[TBL] [Abstract][Full Text] [Related]
6. Reactive oxygen species regulate nucleostemin oligomerization and protein degradation.
Huang M; Whang P; Chodaparambil JV; Pollyea DA; Kusler B; Xu L; Felsher DW; Mitchell BS
J Biol Chem; 2011 Apr; 286(13):11035-46. PubMed ID: 21242306
[TBL] [Abstract][Full Text] [Related]
7. MDM2 binding induces a conformational change in p53 that is opposed by heat-shock protein 90 and precedes p53 proteasomal degradation.
Sasaki M; Nie L; Maki CG
J Biol Chem; 2007 May; 282(19):14626-34. PubMed ID: 17363365
[TBL] [Abstract][Full Text] [Related]
8. GNL3L depletion destabilizes MDM2 and induces p53-dependent G2/M arrest.
Meng L; Hsu JK; Tsai RY
Oncogene; 2011 Apr; 30(14):1716-26. PubMed ID: 21132010
[TBL] [Abstract][Full Text] [Related]
9. Nucleoplasmic mobilization of nucleostemin stabilizes MDM2 and promotes G2-M progression and cell survival.
Meng L; Lin T; Tsai RY
J Cell Sci; 2008 Dec; 121(Pt 24):4037-46. PubMed ID: 19033382
[TBL] [Abstract][Full Text] [Related]
10. Regulation of p53 nuclear export through sequential changes in conformation and ubiquitination.
Nie L; Sasaki M; Maki CG
J Biol Chem; 2007 May; 282(19):14616-25. PubMed ID: 17371868
[TBL] [Abstract][Full Text] [Related]
11. Regulation of p53 and MDM2 activity by MTBP.
Brady M; Vlatkovic N; Boyd MT
Mol Cell Biol; 2005 Jan; 25(2):545-53. PubMed ID: 15632057
[TBL] [Abstract][Full Text] [Related]
12. Oligomerization conditions Mdm2-mediated efficient p53 polyubiquitylation but not its proteasomal degradation.
Hjerpe R; Aillet F; Lopitz-Otsoa F; Lang V; Torres-Ramos M; Farrás R; Hay RT; Rodríguez MS
Int J Biochem Cell Biol; 2010 May; 42(5):725-35. PubMed ID: 20080206
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the MDM2-p53 pathway by the nucleolar protein CSIG in response to nucleolar stress.
Xie N; Ma L; Zhu F; Zhao W; Tian F; Yuan F; Fu J; Huang D; Lv C; Tong T
Sci Rep; 2016 Nov; 6():36171. PubMed ID: 27811966
[TBL] [Abstract][Full Text] [Related]
14. MDMX is essential for the regulation of p53 protein levels in the absence of a functional MDM2 C-terminal tail.
Sanford JD; Yang J; Han J; Tollini LA; Jin A; Zhang Y
BMC Mol Cell Biol; 2021 Sep; 22(1):46. PubMed ID: 34551723
[TBL] [Abstract][Full Text] [Related]
15. Controlled access of p53 to the nucleus regulates its proteasomal degradation by MDM2.
Davis JR; Mossalam M; Lim CS
Mol Pharm; 2013 Apr; 10(4):1340-9. PubMed ID: 23398638
[TBL] [Abstract][Full Text] [Related]
16. MDMX promotes proteasomal turnover of p21 at G1 and early S phases independently of, but in cooperation with, MDM2.
Jin Y; Zeng SX; Sun XX; Lee H; Blattner C; Xiao Z; Lu H
Mol Cell Biol; 2008 Feb; 28(4):1218-29. PubMed ID: 18086887
[TBL] [Abstract][Full Text] [Related]
17. Dynamics in the p53-Mdm2 ubiquitination pathway.
Brooks CL; Gu W
Cell Cycle; 2004 Jul; 3(7):895-9. PubMed ID: 15254415
[TBL] [Abstract][Full Text] [Related]
18. Suppression of the deubiquitinating enzyme USP5 causes the accumulation of unanchored polyubiquitin and the activation of p53.
Dayal S; Sparks A; Jacob J; Allende-Vega N; Lane DP; Saville MK
J Biol Chem; 2009 Feb; 284(8):5030-41. PubMed ID: 19098288
[TBL] [Abstract][Full Text] [Related]
19. C-terminal modifications regulate MDM2 dissociation and nuclear export of p53.
Carter S; Bischof O; Dejean A; Vousden KH
Nat Cell Biol; 2007 Apr; 9(4):428-35. PubMed ID: 17369817
[TBL] [Abstract][Full Text] [Related]
20. Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation.
Itahana K; Mao H; Jin A; Itahana Y; Clegg HV; Lindström MS; Bhat KP; Godfrey VL; Evan GI; Zhang Y
Cancer Cell; 2007 Oct; 12(4):355-66. PubMed ID: 17936560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]